Metabolic syndrome components and disease disability in egyptian multiple sclerosis patients
Autor: | Esraa M. Abd Alrasheed, Rasha M. Fahmi, Takwa H.M. Elkhatib, Mahmoud El Sayed El Ebeary |
---|---|
Rok vydání: | 2020 |
Předmět: |
Adult
Male medicine.medical_specialty Multiple Sclerosis Body Mass Index 03 medical and health sciences 0302 clinical medicine Internal medicine Diabetes mellitus medicine Humans Obesity 030212 general & internal medicine National Cholesterol Education Program Abdominal obesity Metabolic Syndrome Expanded Disability Status Scale business.industry Multiple sclerosis General Medicine medicine.disease Neurology Egypt Female Neurology (clinical) medicine.symptom Metabolic syndrome business Body mass index 030217 neurology & neurosurgery Dyslipidemia |
Zdroj: | Multiple Sclerosis and Related Disorders. 44:102336 |
ISSN: | 2211-0348 |
DOI: | 10.1016/j.msard.2020.102336 |
Popis: | Background There is limited and inconsistent data on metabolic syndrome (MetS) in multiple sclerosis (MS) patients. The aim of this study was to estimate the frequency of MetS and its components in MS patients and to evaluate their association with disease disability in Egyptian MS patients. Methods A cross-section study was carried out on 60 patients (19 males and 41 females) with relapsing remitting MS. All patients were subjected to full general and neurological examination, laboratory and radiological investigations. Assessment of disease disability was performed using Expanded Disability Status Scale (EDSS) and MetS was diagnosed according to National Cholesterol Education Program Adult Treatment Panel Ш (NCEP-ATP III). Results The frequency of MetS in MS patients was 36.7%. Our findings show that 53.3% of MS patients had abdominal obesity, 21.7% had hypertension, 38.3% had diabetes mellitus, 43.3% had elevated triglycerides level and 56.7% had dyslipidemia. Linear regression analysis r evealed that body mass index (BMI), dyslipidemia, current medication and disease duration were significantly associated with disease disability. Conclusion High frequency of MetS and its component was observed in MS patients. Disease duration and current medication as well as some MetS component such as BMI, dyslipidemia, were significantly associated with disability in MS patients. |
Databáze: | OpenAIRE |
Externí odkaz: |